• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

种族差异与前列腺癌:社会经济不平等与基因组学的复杂相互作用。

Racial disparities in prostate cancer: A complex interplay between socioeconomic inequities and genomics.

机构信息

Department of Medicine, Baylor College of Medicine, Houston, TX, USA.

Department of Pathology, Baylor College of Medicine, Houston, TX, USA; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.

出版信息

Cancer Lett. 2022 Apr 10;531:71-82. doi: 10.1016/j.canlet.2022.01.028. Epub 2022 Feb 3.

DOI:10.1016/j.canlet.2022.01.028
PMID:35122875
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9701576/
Abstract

The largest US cancer health disparity exists in prostate cancer, with Black men having more than a two-fold increased risk of dying from prostate cancer compared to all other races. This disparity is a result of a complex network of factors including socioeconomic status (SES), environmental exposures, and genetics/biology. Inequity in the US healthcare system has emerged as a major driver of disparity in prostate cancer outcomes and has raised concerns that the actual incidence rates may be higher than current estimates. However, emerging studies argue that equalizing healthcare access will not fully eliminate racial health disparities and highlight the important role of biology. Significant differences have been observed in prostate cancer biology between ancestral groups that may contribute to prostate cancer health disparities. Notably, relative to White men, Black men with prostate cancer exhibit increased androgen receptor signaling, genomic instability, metabolic dysregulation, and inflammatory and cytokine signaling. Immediate actions are needed to increase multi-center, interdisciplinary research to bridge the gap between social and biological determinants of prostate cancer health disparities.

摘要

美国最大的癌症健康差异存在于前列腺癌中,与其他所有种族相比,黑人男性死于前列腺癌的风险增加了两倍多。这种差异是社会经济地位(SES)、环境暴露和遗传/生物学等多种因素复杂网络的结果。美国医疗保健系统的不平等已成为前列腺癌结果差异的主要驱动因素,并引发了人们的担忧,即实际发病率可能高于目前的估计。然而,新兴研究表明,平等获得医疗保健并不能完全消除种族健康差异,并强调生物学的重要作用。在前列腺癌生物学方面,不同的祖源群体之间存在显著差异,这可能导致前列腺癌健康差异。值得注意的是,与白人男性相比,患有前列腺癌的黑人男性表现出雄激素受体信号增加、基因组不稳定性、代谢失调以及炎症和细胞因子信号。需要立即采取行动,增加多中心、跨学科的研究,以弥合社会和生物决定因素导致的前列腺癌健康差异之间的差距。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8e3/9701576/4fcac2ab6973/nihms-1847239-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8e3/9701576/e4cc18127601/nihms-1847239-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8e3/9701576/8723de2f048d/nihms-1847239-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8e3/9701576/eb7861f65e64/nihms-1847239-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8e3/9701576/8550a18590cd/nihms-1847239-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8e3/9701576/4fcac2ab6973/nihms-1847239-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8e3/9701576/e4cc18127601/nihms-1847239-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8e3/9701576/8723de2f048d/nihms-1847239-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8e3/9701576/eb7861f65e64/nihms-1847239-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8e3/9701576/8550a18590cd/nihms-1847239-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8e3/9701576/4fcac2ab6973/nihms-1847239-f0005.jpg

相似文献

1
Racial disparities in prostate cancer: A complex interplay between socioeconomic inequities and genomics.种族差异与前列腺癌:社会经济不平等与基因组学的复杂相互作用。
Cancer Lett. 2022 Apr 10;531:71-82. doi: 10.1016/j.canlet.2022.01.028. Epub 2022 Feb 3.
2
Health inequity drives disease biology to create disparities in prostate cancer outcomes.健康不平等导致疾病生物学产生前列腺癌结果的差异。
J Clin Invest. 2022 Feb 1;132(3). doi: 10.1172/JCI155031.
3
Genetic and biological drivers of prostate cancer disparities in Black men.导致黑人男性前列腺癌差异的遗传和生物学因素。
Nat Rev Urol. 2024 May;21(5):274-289. doi: 10.1038/s41585-023-00828-w. Epub 2023 Nov 14.
4
Racial disparity in prostate cancer in the African American population with actionable ideas and novel immunotherapies.非裔美国人中前列腺癌的种族差异与可行的治疗思路和新型免疫疗法。
Cancer Rep (Hoboken). 2021 Oct;4(5):e1340. doi: 10.1002/cnr2.1340. Epub 2021 Feb 17.
5
Molecular basis for prostate cancer racial disparities.前列腺癌种族差异的分子基础。
Front Biosci (Landmark Ed). 2017 Jan 1;22(3):428-450. doi: 10.2741/4493.
6
The complex interplay of modifiable risk factors affecting prostate cancer disparities in African American men.影响非裔美国男性前列腺癌差异的可改变风险因素的复杂相互作用。
Nat Rev Urol. 2024 Jul;21(7):422-432. doi: 10.1038/s41585-023-00849-5. Epub 2024 Feb 2.
7
Racial disparities in prostate cancer among black men: epidemiology and outcomes.黑人男性前列腺癌的种族差异:流行病学和结局。
Prostate Cancer Prostatic Dis. 2022 Sep;25(3):397-402. doi: 10.1038/s41391-021-00451-z. Epub 2021 Sep 2.
8
Racial disparities in prostate cancer: a molecular perspective.种族差异与前列腺癌:分子视角
Front Biosci (Landmark Ed). 2017 Jan 1;22(5):772-782. doi: 10.2741/4515.
9
Gaining a deeper understanding of social determinants of preterm birth by integrating multi-omics data.通过整合多组学数据深入了解早产的社会决定因素。
Pediatr Res. 2021 Jan;89(2):336-343. doi: 10.1038/s41390-020-01266-9. Epub 2020 Nov 13.
10
Deconstructing, Addressing, and Eliminating Racial and Ethnic Inequities in Prostate Cancer Care.解构、解决和消除前列腺癌护理中的种族和族裔不平等。
Eur Urol. 2022 Oct;82(4):341-351. doi: 10.1016/j.eururo.2022.03.007. Epub 2022 Mar 30.

引用本文的文献

1
Evaluating a Prostate Cancer Education and Navigation to Screening Program for Black Men in South Carolina, U.S.评估美国南卡罗来纳州针对黑人男性的前列腺癌教育与筛查引导项目
Cancer Control. 2025 Jan-Dec;32:10732748251364046. doi: 10.1177/10732748251364046. Epub 2025 Aug 6.
2
Revolutionizing Prostate Cancer Detection: The Role of Approved PSMA-PET Imaging Agents.革新前列腺癌检测:已获批的PSMA-PET显像剂的作用
Pharmaceuticals (Basel). 2025 Jun 17;18(6):906. doi: 10.3390/ph18060906.
3
ASO Author Reflections: Breast Cancer Among Asian American, Native Hawaiian, and Pacific Islander Patients.

本文引用的文献

1
Differences in Prostate Cancer Genomes by Self-reported Race: Contributions of Genetic Ancestry, Modifiable Cancer Risk Factors, and Clinical Factors.基于自我报告种族的前列腺癌基因组差异:遗传背景、可改变的癌症风险因素和临床因素的贡献。
Clin Cancer Res. 2022 Jan 15;28(2):318-326. doi: 10.1158/1078-0432.CCR-21-2577. Epub 2021 Oct 19.
2
Racial disparities in prostate cancer among black men: epidemiology and outcomes.黑人男性前列腺癌的种族差异:流行病学和结局。
Prostate Cancer Prostatic Dis. 2022 Sep;25(3):397-402. doi: 10.1038/s41391-021-00451-z. Epub 2021 Sep 2.
3
Analysis of Circulating Immune Biomarkers by Race in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Sipuleucel-T.
美国血管外科学会作者反思:亚裔美国人、夏威夷原住民和太平洋岛民患者中的乳腺癌
Ann Surg Oncol. 2025 Jun 16. doi: 10.1245/s10434-025-17510-7.
4
Hormone Therapy Usage Is Associated With Adverse Cardiovascular Events in Prostate Cancer Patients of the All of Us Research Program Cohort.在“我们所有人”研究项目队列的前列腺癌患者中,激素治疗的使用与不良心血管事件相关。
Prostate. 2025 Sep;85(12):1077-1086. doi: 10.1002/pros.24913. Epub 2025 Jun 11.
5
Mediation of Ethnic Disparity in the 5-Year Mortality of Cervical Cancer Patients in the US, 2001-2019.2001 - 2019年美国宫颈癌患者5年死亡率中种族差异的中介作用
Healthcare (Basel). 2025 Apr 22;13(9):964. doi: 10.3390/healthcare13090964.
6
Variation in Prostate Magnetic Resonance Imaging Performance: Data from the Prostate Biopsy Collaborative Group.前列腺磁共振成像性能的差异:来自前列腺活检协作组的数据。
Eur Urol Oncol. 2025 May 2. doi: 10.1016/j.euo.2025.02.007.
7
Upregulation of the interferon-inducible antiviral gene RSAD2 in neuroendocrine prostate cancer via PVT1 exon 9 dependent and independent pathways.通过PVT1第9外显子依赖性和非依赖性途径上调神经内分泌前列腺癌中干扰素诱导的抗病毒基因RSAD2
J Biol Chem. 2025 Apr;301(4):108370. doi: 10.1016/j.jbc.2025.108370. Epub 2025 Feb 28.
8
Increasing Prostate Cancer Education and Screening for Black Men in Southeastern Michigan: Your Prostate, Your Health.提高密歇根州东南部黑人男性的前列腺癌教育水平和筛查率:关注你的前列腺,关注你的健康。
J Cancer Educ. 2025 Feb 28. doi: 10.1007/s13187-025-02588-0.
9
From Unheard to Empowered: Utilizing Communication Accommodation Theory to Address Black Men's With Prostate Cancer Healthcare Preferences.从被忽视到获得权力:运用沟通调适理论来探讨黑人男性前列腺癌患者的医疗保健偏好。
Cancer Control. 2024 Jan-Dec;31:10732748241293987. doi: 10.1177/10732748241293987.
10
The double disparity: Vitamin D deficiency and lethal prostate cancer in black men.双重差异:黑人男性中的维生素D缺乏与致命性前列腺癌
J Steroid Biochem Mol Biol. 2025 Mar;247:106675. doi: 10.1016/j.jsbmb.2025.106675. Epub 2025 Jan 17.
分析接受 sipuleucel-T 治疗的转移性去势抵抗性前列腺癌男性的种族间循环免疫生物标志物。
J Natl Cancer Inst. 2022 Feb 7;114(2):314-317. doi: 10.1093/jnci/djab145.
4
Drivers of racial disparities in prostate cancer trial enrollment.前列腺癌试验入组中种族差异的驱动因素。
Prostate Cancer Prostatic Dis. 2021 Dec;24(4):946-947. doi: 10.1038/s41391-021-00427-z. Epub 2021 Jul 12.
5
Comparative analysis of 1152 African-American and European-American men with prostate cancer identifies distinct genomic and immunological differences.对 1152 名非裔美国男性和欧洲裔美国男性前列腺癌患者进行比较分析,发现了明显的基因组和免疫差异。
Commun Biol. 2021 Jun 3;4(1):670. doi: 10.1038/s42003-021-02140-y.
6
A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer.阿比特龙联合泼尼松治疗转移性去势抵抗性前列腺癌的黑人和白人前瞻性试验。
Cancer. 2021 Aug 15;127(16):2954-2965. doi: 10.1002/cncr.33589. Epub 2021 May 5.
7
Tackling Diversity in Prostate Cancer Clinical Trials: A Report From the Diversity Working Group of the IRONMAN Registry.解决前列腺癌临床试验中的多样性问题:IRONMAN 注册研究多样性工作组的报告。
JCO Glob Oncol. 2021 Apr;7:495-505. doi: 10.1200/GO.20.00571.
8
Response prediction biomarkers and drug combinations of PARP inhibitors in prostate cancer.前列腺癌中 PARP 抑制剂的反应预测生物标志物和药物组合。
Acta Pharmacol Sin. 2021 Dec;42(12):1970-1980. doi: 10.1038/s41401-020-00604-1. Epub 2021 Feb 15.
9
Does the High Prevalence of Vitamin D Deficiency in African Americans Contribute to Health Disparities?非裔美国人中维生素D缺乏的高流行率是否导致了健康差异?
Nutrients. 2021 Feb 3;13(2):499. doi: 10.3390/nu13020499.
10
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.